Cargando…
A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334949/ https://www.ncbi.nlm.nih.gov/pubmed/32682536 http://dx.doi.org/10.1016/j.neurol.2020.06.001 |
| _version_ | 1783554037056012288 |
|---|---|
| author | EL Aoud, S. Sorial, D. Selmaoui, A. Menif, I. Lazard, M. Si Hocine, M. Thomas, L. |
| author_facet | EL Aoud, S. Sorial, D. Selmaoui, A. Menif, I. Lazard, M. Si Hocine, M. Thomas, L. |
| author_sort | EL Aoud, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7334949 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73349492020-07-06 A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 EL Aoud, S. Sorial, D. Selmaoui, A. Menif, I. Lazard, M. Si Hocine, M. Thomas, L. Rev Neurol (Paris) Letter to the Editor Elsevier Masson SAS. 2021 2020-07-04 /pmc/articles/PMC7334949/ /pubmed/32682536 http://dx.doi.org/10.1016/j.neurol.2020.06.001 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor EL Aoud, S. Sorial, D. Selmaoui, A. Menif, I. Lazard, M. Si Hocine, M. Thomas, L. A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 |
| title | A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 |
| title_full | A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 |
| title_fullStr | A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 |
| title_full_unstemmed | A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 |
| title_short | A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 |
| title_sort | first case of mild encephalitis with reversible splenial lesion(mers) as a presenting feature of sars-cov-2 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334949/ https://www.ncbi.nlm.nih.gov/pubmed/32682536 http://dx.doi.org/10.1016/j.neurol.2020.06.001 |
| work_keys_str_mv | AT elaouds afirstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT soriald afirstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT selmaouia afirstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT menifi afirstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT lazardm afirstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT sihocinem afirstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT thomasl afirstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT elaouds firstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT soriald firstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT selmaouia firstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT menifi firstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT lazardm firstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT sihocinem firstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 AT thomasl firstcaseofmildencephalitiswithreversiblespleniallesionmersasapresentingfeatureofsarscov2 |